EBG Advisors, Inc., is a Washington, D.C., consultancy that addresses strategy and public policy issues for medical device manufacturers; developers of biosciences innovations; providers of health care services; trade associations, coalitions, and alliances; private-equity and investment firms; and other organizations interested in health care.
EBG Advisors is affiliated with the law firm of Epstein Becker & Green, P.C., which has a health care and life sciences legal practice that is among the nation's largest.
Overview
EBG Advisors helps emerging and established companies gain a competitive advantage in the health care marketplace with its distinctive blend of deep health care and life science experience, regulatory insights, and innovative thinking. This combination helps clients: navigate complex regulatory environments and payment systems; assess, create, and capture growth opportunities; and better position themselves to achieve their objectives.
Knowledge Management
EBG Advisors systematically acquires and analyzes intelligence from multiple sources that influence health care policy, like Health and Human Services' Office of Consumer Insurance Information and Oversight (OCIIO), Centers for Medicare & Medicaid Services, Capitol Hill, MedPAC, ONC, AHRQ, the CPT Advisory Panel, and physician specialty societies. Drawing upon this knowledge, EBG Advisors is able to provide clients customized, cost-effective advisory services on issues that touch virtually every health care and biosciences sector.
Services
Key service areas include reimbursement planning for new and mature devices and drugs; collection and synthesis of health care knowledge for private-equity firms and other investors; and public policy assessments and analyses for corporate and association government affairs and policy professionals.
Cal-INFRA Advisors, Inc.
Reimbursed Markets
EBG Advisors provides clients a platform for evaluating the reimbursement environment on a continuing basis. We work with clients to understand and assess the impact of Medicare and other third-party coverage and
reimbursement decisions, this
includes identifying
significant
developments
and defining
structured
opportunities
for engagement.
